pemvidutide
pemvidutide: sourced relationships with 1 company · 3 clinical trials tracked.
pemvidutide evidence translation
What we can confirm
3 tracked trials
What it means
What to watch
Prepared research question
How could pemvidutide → ALT affect its developer, and what evidence supports the link?
Traceable citations · Unknowns marked
See linked entities and source evidence2 indications · 0 study sponsors
Related indications
Study sponsors
No additional listed-company sponsor is linked.
Dated Pipeline Records (3)
| Company | Dated record stage |
|---|---|
| Altimmune, Inc. (ALT) Alcohol-associated Liver Disease; Metabolic Dysfunction-Asso… | Phase 3 |
| Altimmune, Inc. (ALT) Alcohol-associated Liver Disease; Metabolic Dysfunction-Asso… | Phase 3 |
| Altimmune, Inc. (ALT) Alcohol-associated Liver Disease; Metabolic Dysfunction-Asso… | Phase 3 |
Clinical Trial Registry Records (3)
A Phase 3, Multinational, Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Evaluate the Efficacy, Safety, and Clinical Outcomes of Pemvidutide in Subjects With Noncirrhotic Metabolic Dysfunction-Associated Steatohepatitis (MASH)
Primary endpoint: Clinical Outcome Event
RESTORE TRIAL: A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled Study Evaluating the Efficacy and Safety of Pemvidutide in the Treatment of Alcohol-Associated Liver Disease (ALD)
Primary endpoint: Relative (%) reduction in liver stiffness by VCTE compared to baseline
RECLAIM STUDY: A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled Study Evaluating the Efficacy and Safety of Pemvidutide in the Treatment of Alcohol Use Disorder (AUD) in Subjects With Obesity or Overweight
Primary endpoint: Change from baseline in the average number of heavy drinking days per week
Frequently asked questions
Which companies have sourced relationships with pemvidutide?
pemvidutide has dated SEC/FDA relationship records for Altimmune, Inc..
How many clinical trials involve pemvidutide?
BioSniper tracks 3 clinical trials involving pemvidutide.